Rheumatoid arthritis in Saudi Arabia

Saudi Medical Journal

Volumn 35, Issue 12, 2014, Pages 1442-1454

  Almoallim, Hani M ^a   Alharbi, Laila A ^a  

^a DR SOLIMAN FAKEEH HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 6; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; ANTIRHEUMATIC AGENT;

BONE DENSITY; CD4+ T LYMPHOCYTE; CERVICAL SPINE; COMORBIDITY; DIABETES MELLITUS; DYSLIPIDEMIA; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; HYPERTENSION; MEDLINE; OSTEOPOROSIS; PATIENT COUNSELING; PREVALENCE; QUESTIONNAIRE; RADIODIAGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHEUMATOID ARTHRITIS; SAUDI ARABIA; SLEEP DISORDERED BREATHING; SYSTEMATIC REVIEW; ARTHRITIS, RHEUMATOID; IMMUNOLOGY; MEDICAL RESEARCH; PRACTICE GUIDELINE; REGISTER;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOMEDICAL RESEARCH; HUMANS; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; SAUDI ARABIA;

EID: 84918521089     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. Mjaavatten MD, Bykerk VP. Early rheumatoid arthritis: the performance of the 2010 ACR/EULAR criteria for diagnosing RA. Best Pract Res Clin Rheumatol 2013; 27: 451-466.
2. Padyukov L, Lampa J, Heimbürger M, Ernestam S, Cederholm T, et al. Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis. Ann Rheum Dis 2003; 62: 526-529.
3. Sanmartí R, Ruiz-Esquide V, Hernández MV. Rheumatoid arthritis: a clinical overview of new diagnostic and treatment approaches. Curr Top Med Chem 2013; 13: 698-704.
4. Grassi W, Davies A, Boumendil O. Recent Trends and Technology Advances in Rheumatoid Arthritis Clinical and Ultrasonography and Power Doppler Imaging. European Musculoskeletal Review 2011; 6: 148-152.
5. Atwa MA, Balata MG, Hussein AM, Abdelrahman NI, Elminshawy HH. Serum 25-hydroxyvitamin D concentration in patients with psoriasis and rheumatoid arthritis and its association with disease activity and serum tumor necrosis factor-alpha. Saudi Med J 2013; 34: 806-813.
6. Safi M-AA, Houssien DA, Scott DL. Disease Activity and Anti-Cyclic Citrullinated Peptide (Anti-CCP) Antibody in Saudi RF-Negative Rheumatoid Arthritis Patients. JKAU Med Sci 2012; 19: 3-20.
7. Al-Arfaj A. HLA-DR pattern of rheumatoid arthritis in Saudi Arabia. Ann Saudi Med 2001; 21: 92-93.
8. Al-Ghamdi A. The Co-Morbidities and Mortality Rate among Rheumatoid Arthritis Patients at the Western Region of Saudi Arabia. JKAU Med Sci 2009; 16:15-29.
9. Al Rikabi AC, Naddaf HO, al Balla SR, al Sohaibani MO. Proteinaceous lymphadenopathy in a patient with known rheumatoid arthritis--case report and review of the literature. Br J Rheumatol 1995; 34: 1087-1089.
10. Al-Arfaj HF. Klinefelter’s syndrome and rheumatoid arthritis: report of a case and review of the literature. Int J Rheum Dis 2010; 13: 86-88.
11. Bakheet SM, Powe J. Fluorine-18-fluorodeoxyglucose uptake in rheumatoid arthritis-associated lung disease in a patient with thyroid cancer. J Nucl Med 1998; 39: 234-236.
12. Al-Anazi KA, Eltayeb KI, Bakr M, Al-Mohareb FI. Methotrexate-induced acute leukemia: report of three cases and review of the literature. Clin Med Case Rep 2009; 2: 43-49.
13. Abu-Shraie NA, Alfadley AA. Lichenoid drug eruption probably associated with rofecoxib. Ann Pharmacother 2004; 38: 795-798.
14. Attar SM, Bunting PS, Smith CD, Karsh J. Comparison of the anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis at an arthritis center. Saudi Med J 2009; 30: 446-447.
15. Rajapakse CN. The spectrum of rheumatic diseases in Saudi Arabia. Br J Rheumatol 1987; 26: 22-23.
16. Alballa SR. The expression of rheumatoid arthritis in Saudi Arabia. Clin Rheumatol 1995; 14: 641-645.
17. Al-Arfaj AS. Characteristics of rheumatoid arthritis relative to HLA-DR in Saudi Arabia. Saudi Med J 2001; 22: 595-598.
18. Al-Ghamdi A, Attar SM. Extra-articular manifestations of rheumatoid arthritis: a hospital-based study. Ann Saudi Med 2009; 29: 189-193.
19. Noorwali AA. Bone density in rheumatoid arthritis. Saudi Med J 2004; 25: 766-769.
20. Al-Ahaideb A. Septic arthritis in patients with rheumatoid arthritis. J Orthop Surg Res 2008; 3: 33.
21. Attar SM. Adverse effects of low dose methotrexate in rheumatoid arthritis patients. A hospital-based study. Saudi Med J 2010; 31: 909-915.
22. Attar SM, Al-Ghamdi A. Radiological changes in rheumatoid arthritis patients at a teaching hospital in Saudi Arabia. East Mediterr Health J 2010; 16: 953-957.
23. Al-Ahaideb A, Drosdowech DS, Pichora DR. Fractional flexor tendon lengthening for advanced metacarpophalangeal flexion contracture in rheumatoid hands. J Hand Surg Am 2006; 31: 1690-1693.
24. Al-Bishri J, Attar S, Bassuni N, Al-Nofaiey Y, Qutbuddeen H, Al-Harthi S, et al. Comorbidity profile among patients with rheumatoid arthritis and the impact on prescriptions trend. Clin Med Insights Arthritis Musculoskelet Disord 2013; 6: 11-18.
25. Janoudi N, Almoallim H, Husien W, Noorwali A, Ibrahim A. Work ability and work disability evaluation in Saudi patients with rheumatoid arthritis. Special emphasis on work ability among housewives. Saudi Med J 2013; 34: 1167-1172.
26. Khan WA, Khan MW. Cancer morbidity in rheumatoid arthritis: role of estrogen metabolites. Biomed Res Int 2013; 2013: 748178.
27. Almoallim H, Al-Ghamdi Y, Almaghrabi H, Alyasi O. Anti-Tumor Necrosis Factor-a Induced Systemic Lupus Erythematosus. Open Rheumatol J 2012; 6: 315-319.
28. Almoallim H, Kamil A. Rheumatoid arthritis: should we shift the focus from “Treat to Target” to “Treat to Work?”. Clin Rheumatol 2013; 32: 285-287.
29. Bissar L, Almoallim H, Albazli K, Alotaibi M, Alwafi S. Perioperative management of patients with rheumatic diseases. Open Rheumatol J 2013; 7: 42-50.
30. Al-Dalaan A, Al Ballaa S, Bahabri S, Biyari T, Al Sukait M, Mousa M. The prevalence of rheumatoid arthritis in the Qassim region of Saudi Arabia. Ann Saudi Med 1998; 18: 396-397.
31. Al-Swailem R, Al-Rayes H, Sobki S, Arfin M, Tariq M. HLA-DRB1 association in Saudi rheumatoid arthritis patients. Rheumatol Int 2006; 26: 1019-1024.
32. Habib HM, Eisa AA, Arafat WR, Marie MA. Pulmonary involvement in early rheumatoid arthritis patients. Clin Rheumatol 2011; 30: 217-221.
33. Alamoudi OS. Sleep-disordered breathing in patients with acquired retrognathia secondary to rheumatoid arthritis. Med Sci Monit 2006; 12: CR530-CR534.
34. Javed F, Ahmed HB, Mikami T, Almas K, Romanos GE, Al-Hezaimi K. Cytokine profile in the gingival crevicular fluid of rheumatoid arthritis patients with chronic periodontitis. J Investig Clin Dent 2014; 5: 1-8.
35. Abd-Allah AR, Ahmad SF, Alrashidi I, Abdel-Hamied HE, Zoheir KM, Ashour AE, et al. Involvement of histamine 4 receptor in the pathogenesis and progression of rheumatoid arthritis. Int Immunol 2014; 26: 325-340.
36. Ahmad SF, Attia SM, Zoheir KM, Ashour AE, Bakheet SA. Attenuation of the progression of adjuvant-induced arthritis by 3-aminobenzamide treatment. Int Immunopharmacol 2014; 19: 52-59.
37. Ahmad SF, Zoheir KM, Abdel-Hamied HE, Ashour AE, Bakheet SA, Attia SM, et al. Grape seed proanthocyanidin extract has potent anti-arthritic effects on collageninduced arthritis by modifying the T cell balance. Int Immunopharmacol 2013; 17: 79-87.
38. Ramadan G, El-Menshawy O. Protective effects of ginger-turmeric rhizomes mixture on joint inflammation, atherogenesis, kidney dysfunction and other complications in a rat model of human rheumatoid arthritis. Int J Rheum Dis 2013; 16: 219-229.
39. al-Janadi M, al-Balla S, al-Dalaan A, Raziuddin S. Cytokine production by helper T cell populations from the synovial fluid and blood in patients with rheumatoid arthritis. J Rheumatol 1993; 20: 1647-1653.
40. al-Janadi M, al-Dalaan A, al-Balla S, al-Humaidi M, Raziuddin S. Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10- dependent CD4+CD45RO+ T cell-B cell antibody synthesis. J Clin Immunol 1996; 16: 198-207.
41. al-Janadi N, al-Dalaan A, al-Balla S, Raziuddin S. CD4+ T cell inducible immunoregulatory cytokine response in rheumatoid arthritis. J Rheumatol 1996; 23: 809-814.
42. Haq A, El-Ramahi K, Al-Dalaan A, Al-Sedairy ST. Serum and synovial fluid concentrations of endothelin-1 in patients with rheumatoid arthritis. J Med 1999; 30: 51-60.
43. Al-Rayes H, Al-Swailem R, Albelawi M, Arfin M, Al-Asmari A, Tariq M. TNF-α and TNF-β Gene Polymorphism in Saudi Rheumatoid Arthritis Patients. Clin Med Insights Arthritis Musculoskelet Disord 2011; 4: 55-63.
44. al-Mobireek AF, Darwazeh AM, Hassanin MB. Experimental induction of rheumatoid arthritis in temporomandibular joint of the guinea pig: a clinical and radiographic study. Dentomaxillofac Radiol 2000; 29: 286-290.
45. Sankaran-Kutty M, Das PK, Kannan Kutty M. Synovial biopsy. A comparative study from Saudi Arabia and Malaysia. Int Orthop 1998; 22: 189-192.
46. el-Hazmi MA, al-Ballaa SR, Warsy AS, al-Arfaj H, al-Sughari S, al-Dalaan AN. Transferrin C subtypes in patients with rheumatoid arthritis. Br J Rheumatol 1991; 30: 21-23.
47. Hussein YM, Mohamed RH, El-Shahawy EE, Alzahrani SS. Interaction between TGF-β1 (869C/T) polymorphism and biochemical risk factor for prediction of disease progression in rheumatoid arthritis. Gene 2014; 536: 393-397.
48. Khan WA, Moinuddin, Assiri AS. Immunochemical studies on catechol-estrogen modified plasmid: possible role in rheumatoid arthritis. J Clin Immunol 2011; 31: 22-29.
49. Attar SM. Vitamin D deficiency in rheumatoid arthritis. Prevalence and association with disease activity in Western Saudi Arabia. Saudi Med J 2012; 33: 520-525.
50. Al-Arfaj AS, Al-Boukai AA. Patterns of radiographic changes in hands and feet of rheumatoid arthritis in Saudi Arabia. Saudi Med J 2005; 26: 1065-1067.
51. Al-Boukai AA, Al-Arfaj AS. Rheumatoid arthritis. Radiological changes in the cervical spine. Saudi Med J 2003; 24: 396-399.
52. Dewedar AM, Shalaby MA, Al-Homaid S, Mahfouz AM, Shams OA, Fathy A. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up. Int J Rheum Dis 2012; 15: 330-335.
53. Eleishi HH, Toma NF, Chaki MC, Nada HR. Three years experience with the prescription of anti-TNF-alpha inhibitors at Dr Soliman Fakeeh Hospital in Jeddah, Saudi Arabia. Int J Rheum Dis 2009; 12: 14-19.
54. Almoallim H, Attar S, Jannoudi N, Al-Nakshabandi N, Eldeek B, Fathaddien O, et al. Sensitivity of standardised musculoskeletal examination of the hand and wrist joints in detecting arthritis in comparison to ultrasound findings in patients attending rheumatology clinics. Clin Rheumatol 2012; 31: 1309-1317.
55. Backhaus M, Ohrndorf S, Kellner H, Strunk J, Backhaus TM, Hartung W, et al. Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project. Arthritis Rheum 2009; 61: 1194-1201.
56. Thiele RG. Ultrasonography applications in diagnosis and management of early rheumatoid arthritis. Rheum Dis Clin North Am 2012; 38: 259-275.
57. Szkudlarek M, Klarlund M, Narvestad E, Court-Payen M, Strandberg C, Jensen KE, et al. Ultrasonography of the metacarpophalangeal and proximal interphalangeal joints in rheumatoid arthritis: a comparison with magnetic resonance imaging, conventional radiography and clinical examination. Arthritis Res Ther 2006; 8: R52.
58. Wakefield RJ, Green MJ, Marzo-Ortega H, Conaghan PG, Gibbon WW, McGonagle D, et al. Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease. Ann Rheum Dis 2004; 63: 382-385.
59. Vlad V, Berghea F, Libianu S, Balanescu A, Bojinca V, Constantinescu C, et al. Ultrasound in rheumatoid arthritis: volar versus dorsal synovitis evaluation and scoring. BMC Musculoskelet Disord 2011; 12: 124.
60. Magni-Manzoni S, Epis O, Ravelli A, Klersy C, Veisconti C, Lanni S, et al. Comparison of clinical versus ultrasounddetermined synovitis in juvenile idiopathic arthritis. Arthritis Rheum 2009; 61: 1497-1504.
61. Wakefield RJ, Gibbon WW, Conaghan PG, O’Connor P, McGonagle D, Pease C, et al. The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography. Arthritis Rheum 2000; 43: 2762-2770.
62. Filer A, de Pablo P, Allen G, Nightingale P, Jordan A, Jobanputra P, et al. Utility of ultrasound joint counts in the prediction of rheumatoid arthritis in patients with very early synovitis. Ann Rheum Dis 2011; 70: 500-507.
63. Sokka T, Rannio T, Khan NA. Disease activity assessment and patient-reported outcomes in patients with early rheumatoid arthritis. Rheum Dis Clin North Am 2012; 38: 299-310.
64. Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010; 69: 964-975.
65. Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012; 64: 625-639.
66. Haraoui B, Smolen JS, Aletaha D, Breedveld FC, Burmester G, Codreanu C, et al. Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire. Ann Rheum Dis 2011; 70: 1999-2002.
67. Theis KA, Murphy L, Hootman JM, Helmick CG, Yelin E. Prevalence and correlates of arthritis-attributable work limitation in the US population among persons ages 18-64: 2002 National Health Interview Survey Data. Arthritis Rheum 2007; 57: 355-363.
68. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008; 58: 15-25.
69. Jäntti J, Aho K, Kaarela K, Kautiainen H. Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study. Rheumatology (Oxford) 1999; 38: 1138-1141.
70. Sokka T, Kautiainen H, Möttönen T, Hannonen P. Work disability in rheumatoid arthritis 10 years after the diagnosis. J Rheumatol 1999; 26: 1681-1685.
71. Barrett EM, Scott DG, Wiles NJ, Symmons DP. The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study. Rheumatology (Oxford) 2000; 39: 1403-1409.
72. Eberhardt K, Larsson BM, Nived K, Lindqvist E. Work disability in rheumatoid arthritis--development over 15 years and evaluation of predictive factors over time. J Rheumatol 2007; 34: 481-487.
73. Klimes J, Dolezal T, Vocelka M, Petrikova A, Kruntoradova K. The effect of biological treatment on work productivity and productivity costs of rheumatoid arthritis patients. Value in Health 2011; 14: A305.
74. Mau W, Bornmann M, Weber H, Weidemann HF, Hecker H, Raspe HH. Prediction of permanent work disability in a follow-up study of early rheumatoid arthritis: results of a tree structured analysis using RECPAM. Br J Rheumatol 1996; 35: 652-659.
75. Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Hakala M, et al. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. Arthritis Rheum 2005; 52: 36-41.
76. Emery P, Dörner T. Optimising treatment in rheumatoid arthritis: a review of potential biological markers of response. Ann Rheum Dis 2011; 70: 2063-2070.
77. Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2014; 506: 376-381.
78. Zaini R, Almoallim H, AlRehaily A, Samannodi M, Bawayan M, Hafiz W, et al. [AB1407] Musculoskeletal teaching and training in Saudi Arabia: a national survey. Ann Rheum Dis 2012; 71 (Suppl 3): 718.
79. Almoallim H, Kalantan D, Shabrawishi M, Mandili F, Hafiz H, Samannodi M, et al. Basic Skills in Musculoskeletal Examination: Hands-on Training Workshop. [Updated: 2013]. Available from: https://www.mededportal.org/publication/9398 http://dx.doi.org/10.15766/mep_2374- 8265.9398
80. Scott DL, Choy EH, Greeves A, Isenberg D, Kassinor D, Rankin E, et al. Standardising joint assessment in rheumatoid arthritis. Clin Rheumatol 1996; 15: 579-582.
81. Matzkin E, Smith EL, Freccero D, Richardson AB. Adequacy of education in musculoskeletal medicine. J Bone Joint Surg Am 2005; 87: 310-314.
82. Day CS, Yeh AC, Franko O, Ramirez M, Krupat E. Musculoskeletal medicine: an assessment of the attitudes and knowledge of medical students at Harvard Medical School. Acad Med 2007; 82: 452-457.
83. Clawson DK, Jackson DW, Ostergaard DJ. It’s past time to reform the musculoskeletal curriculum. Acad Med 2001; 76: 709-710.
84. Clark ML, Hutchison CR, Lockyer JM. Musculoskeletal education: a curriculum evaluation at one university. BMC Med Educ 2010; 10: 93.
85. Akesson K, Dreinhöfer KE, Woolf AD. Improved education in musculoskeletal conditions is necessary for all doctors. Bull World Health Organ 2003; 81: 677-683.
86. Goldenberg DL, DeHoratius RJ, Kaplan SR, Mason J, Meenan R, Perlman SG, et al. Rheumatology training at internal medicine and family practice residency programs. Arthritis Rheum 1985; 28: 471-476.
87. Pinney SJ, Regan WD. Educating medical students about musculoskeletal problems. Are community needs reflected in the curricula of Canadian medical schools? J Bone Joint Surg Am 2001; 83: 1317-1320.
88. Dequeker J, Esselens G, Westhovens R. Educational issues in rheumatology. The musculoskeletal examination: a neglected skill. Clin Rheumatol 2007; 26: 5-7.
89. Coady DA, Walker DJ, Kay LJ. Teaching medical students musculoskeletal examination skills: identifying barriers to learning and ways of overcoming them. Scand J Rheumatol 2004; 33: 47-51.
90. Freedman KB, Bernstein J. Educational deficiencies in musculoskeletal medicine. J Bone Joint Surg Am 2002; 84: 604-608.
91. Oswald AE, Bell MJ, Snell L, Wiseman J. The current state of musculoskeletal clinical skills teaching for preclerkship medical students. J Rheumatol 2008; 35: 2419-2426.
92. Association of American Medical Colleges. Report VII, Contemporary issues in medicine: Muscluskeletal Medicine Education. Washington (DC): Association of American Medical Colleges; 2005.
93. Clark ML, Hutchison CR, Lockyer JM. Musculoskeletal education: a curriculum evaluation at one university. BMC Med Educ 2010; 10: 93.
94. Ministry of Health. The Annual Health Report - 1430H- 20Riyadh (KSA): Ministry of Health; 2009.
95. Thompson AE. Improving undergraduate musculoskeletal education: a continuing challenge. J Rheumatol 2008; 35: 2298-2299.
96. Woolf AD, Akesson K. Primer: history and examination in the assessment of musculoskeletal problems. Nat Clin Pract Rheumatol 2008; 4: 26-33.
97. Joshua AM, Celermajer DS, Stockler MR. Beauty is in the eye of the examiner: reaching agreement about physical signs and their value. Intern Med J 2005; 35: 178-187.
98. van den Bemt BJ, Zwikker HE, van den Ende CH. Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Expert Rev Clin Immunol 2012; 8: 337-351.
99. Kamel M, Serafi T. Fucose concentrations in sera from patients with rheumatoid arthritis. Clin Exp Rheumatol 1995; 13: 243-246.
100. Alorainy M. Effect of allopurinol and vitamin e on rat model of rheumatoid arthritis. Int J Health Sci (Qassim) 2008; 2: 59-67.
101. Arafa NM, Hamuda HM, Melek ST, Darwish SK. The effectiveness of Echinacea extract or composite glucosamine, chondroitin and methyl sulfonyl methane supplements on acute and chronic rheumatoid arthritis rat model. Toxicol Ind Health 2013; 29: 187-201.
102. Daba MH, El-Tahir KE, Al-Arifi MN, Gubara OA. Druginduced pulmonary fibrosis. Saudi Med J 2004; 25: 700-706.